GE HealthCare, a subsidiary of General Electric, is a leading player in the global healthcare industry, headquartered in the United States. Founded in 1892, the company has evolved significantly, marking key milestones such as the introduction of advanced imaging technologies and innovative patient monitoring systems. With a strong presence in North America, Europe, and Asia, GE HealthCare focuses on medical imaging, monitoring, biomanufacturing, and digital solutions. Its core products, including MRI machines, ultrasound systems, and healthcare IT solutions, are renowned for their cutting-edge technology and reliability. As a pioneer in healthcare innovation, GE HealthCare has consistently maintained a strong market position, recognised for its commitment to improving patient outcomes and operational efficiency in healthcare settings worldwide.
How does GE HealthCare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
GE HealthCare's score of 82 is higher than 91% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, GE HealthCare reported total carbon emissions of approximately 6,064,000,000 kg CO2e, with emissions distributed across various scopes: 105,000,000 kg CO2e (Scope 1), 116,000,000 kg CO2e (Scope 2), and 6,064,000,000 kg CO2e (Scope 3). The Scope 3 emissions primarily stem from downstream leased assets, accounting for about 4,094,000,000 kg CO2e. The company has set ambitious climate commitments, aiming to achieve net zero greenhouse gas emissions across its value chain by 2050. In the near term, GE HealthCare targets a 42% reduction in absolute Scope 1 and 2 emissions by 2030, using a 2022 baseline. Additionally, it aims for a 25% reduction in Scope 3 emissions from purchased goods and services, upstream transportation and distribution, business travel, and the use of sold products by the same year. These targets are aligned with the Science Based Targets initiative (SBTi), which classifies GE HealthCare's near-term targets as consistent with limiting global warming to 1.5°C. The company also aims for a long-term reduction of 90% in absolute Scope 1, 2, and 3 emissions by 2050, again using 2022 as the baseline year. GE HealthCare's commitment to sustainability reflects its proactive approach to addressing climate change within the healthcare equipment and supplies sector, headquartered in the United States.
Access structured emissions data, company-specific emission factors, and source documents
2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|---|---|---|
Scope 1 | 1,670,000,000 | 0,000,000,000 | 000,000,000 | 000,000,000 | 000,000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 2 | - | - | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
Scope 3 | 2,790,000,000 | 0,000,000,000 | - | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
GE HealthCare is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.